nodes	percent_of_prediction	percent_of_DWPC	metapath
Prasugrel—CYP2C19—urine—nephrolithiasis	0.0875	0.186	CbGeAlD
Prasugrel—CYP2C9—urine—nephrolithiasis	0.0678	0.144	CbGeAlD
Prasugrel—CYP3A4—urine—nephrolithiasis	0.0517	0.11	CbGeAlD
Prasugrel—CES2—nephron tubule—nephrolithiasis	0.0511	0.109	CbGeAlD
Prasugrel—CES2—renal system—nephrolithiasis	0.0464	0.0989	CbGeAlD
Prasugrel—CES2—kidney—nephrolithiasis	0.0449	0.0956	CbGeAlD
Prasugrel—CES2—cortex of kidney—nephrolithiasis	0.0437	0.0931	CbGeAlD
Prasugrel—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0378	0.206	CbGpPWpGaD
Prasugrel—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0358	0.103	CcSEcCtD
Prasugrel—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0273	0.0785	CcSEcCtD
Prasugrel—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0233	0.0672	CcSEcCtD
Prasugrel—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0197	0.0569	CcSEcCtD
Prasugrel—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0187	0.0539	CcSEcCtD
Prasugrel—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0187	0.0539	CcSEcCtD
Prasugrel—CES2—NRF2 pathway—SLC2A9—nephrolithiasis	0.0185	0.101	CbGpPWpGaD
Prasugrel—CYP2B6—nephron tubule—nephrolithiasis	0.0184	0.0393	CbGeAlD
Prasugrel—CYP2B6—renal system—nephrolithiasis	0.0168	0.0357	CbGeAlD
Prasugrel—CYP2B6—kidney—nephrolithiasis	0.0162	0.0345	CbGeAlD
Prasugrel—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0151	0.0821	CbGpPWpGaD
Prasugrel—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0396	CcSEcCtD
Prasugrel—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0392	CcSEcCtD
Prasugrel—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0132	0.038	CcSEcCtD
Prasugrel—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0367	CcSEcCtD
Prasugrel—CYP3A4—renal system—nephrolithiasis	0.0127	0.027	CbGeAlD
Prasugrel—CYP3A4—kidney—nephrolithiasis	0.0122	0.0261	CbGeAlD
Prasugrel—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0314	CcSEcCtD
Prasugrel—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0104	0.03	CcSEcCtD
Prasugrel—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0297	CcSEcCtD
Prasugrel—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0291	CcSEcCtD
Prasugrel—Cough—Hydrochlorothiazide—nephrolithiasis	0.00983	0.0283	CcSEcCtD
Prasugrel—P2RY12—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00968	0.0527	CbGpPWpGaD
Prasugrel—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0092	0.0265	CcSEcCtD
Prasugrel—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.009	0.0259	CcSEcCtD
Prasugrel—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00859	0.0248	CcSEcCtD
Prasugrel—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0082	0.0236	CcSEcCtD
Prasugrel—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00793	0.0228	CcSEcCtD
Prasugrel—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00727	0.0209	CcSEcCtD
Prasugrel—P2RY12—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00687	0.0374	CbGpPWpGaD
Prasugrel—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00678	0.0195	CcSEcCtD
Prasugrel—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0066	0.019	CcSEcCtD
Prasugrel—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00629	0.0181	CcSEcCtD
Prasugrel—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00608	0.0175	CcSEcCtD
Prasugrel—Rash—Hydrochlorothiazide—nephrolithiasis	0.0058	0.0167	CcSEcCtD
Prasugrel—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00579	0.0167	CcSEcCtD
Prasugrel—Headache—Hydrochlorothiazide—nephrolithiasis	0.00576	0.0166	CcSEcCtD
Prasugrel—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00546	0.0157	CcSEcCtD
Prasugrel—P2RY12—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00439	0.0239	CbGpPWpGaD
Prasugrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00376	0.0205	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—SLC7A9—nephrolithiasis	0.00354	0.0193	CbGpPWpGaD
Prasugrel—P2RY12—Hemostasis—DGKH—nephrolithiasis	0.00354	0.0193	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—RGS14—nephrolithiasis	0.00331	0.018	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—RGS14—nephrolithiasis	0.00301	0.0164	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—CHRM3—nephrolithiasis	0.00286	0.0156	CbGpPWpGaD
Prasugrel—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.00278	0.0151	CbGpPWpGaD
Prasugrel—P2RY12—GPCR ligand binding—PTH—nephrolithiasis	0.00262	0.0143	CbGpPWpGaD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00261	0.0142	CbGpPWpGaD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00238	0.013	CbGpPWpGaD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00238	0.013	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—DGKH—nephrolithiasis	0.00224	0.0122	CbGpPWpGaD
Prasugrel—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.0021	0.0114	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ADCY10—nephrolithiasis	0.00209	0.0114	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—DGKH—nephrolithiasis	0.00203	0.0111	CbGpPWpGaD
Prasugrel—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00191	0.0104	CbGpPWpGaD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00181	0.00984	CbGpPWpGaD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00181	0.00984	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—RGS14—nephrolithiasis	0.00178	0.00968	CbGpPWpGaD
Prasugrel—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.0017	0.00929	CbGpPWpGaD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00168	0.00915	CbGpPWpGaD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00168	0.00915	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00162	0.00881	CbGpPWpGaD
Prasugrel—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0015	0.00816	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00149	0.0081	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00149	0.0081	CbGpPWpGaD
Prasugrel—P2RY12—GPCR downstream signaling—PTH—nephrolithiasis	0.00148	0.00806	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—CHRM3—nephrolithiasis	0.00147	0.008	CbGpPWpGaD
Prasugrel—P2RY12—Signaling by GPCR—PTH—nephrolithiasis	0.00134	0.00732	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00132	0.00722	CbGpPWpGaD
Prasugrel—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00126	0.00687	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00121	0.0066	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00121	0.0066	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0012	0.00654	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—DGKH—nephrolithiasis	0.0012	0.00654	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000918	0.005	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000918	0.005	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.000879	0.00479	CbGpPWpGaD
Prasugrel—ALB—Hemostasis—DGKH—nephrolithiasis	0.000879	0.00479	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—CHRM3—nephrolithiasis	0.000868	0.00473	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000853	0.00465	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000853	0.00465	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—PTH—nephrolithiasis	0.000794	0.00432	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000761	0.00414	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000761	0.00414	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—GRHPR—nephrolithiasis	0.000627	0.00341	CbGpPWpGaD
Prasugrel—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000608	0.00331	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AGXT—nephrolithiasis	0.000558	0.00304	CbGpPWpGaD
Prasugrel—ALB—Metabolism—GRHPR—nephrolithiasis	0.000527	0.00287	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	0.000475	0.00259	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—APRT—nephrolithiasis	0.000475	0.00259	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000473	0.00258	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AGXT—nephrolithiasis	0.00047	0.00256	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000432	0.00235	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000422	0.0023	CbGpPWpGaD
Prasugrel—ALB—Metabolism—APRT—nephrolithiasis	0.0004	0.00218	CbGpPWpGaD
Prasugrel—ALB—Metabolism—SLC26A1—nephrolithiasis	0.0004	0.00218	CbGpPWpGaD
Prasugrel—P2RY12—Signaling Pathways—SPP1—nephrolithiasis	0.000398	0.00217	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000385	0.0021	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000359	0.00195	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000359	0.00195	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—AQP1—nephrolithiasis	0.000338	0.00184	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000327	0.00178	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000327	0.00178	CbGpPWpGaD
Prasugrel—CYP2B6—Metabolism—CHRM3—nephrolithiasis	0.000306	0.00167	CbGpPWpGaD
Prasugrel—ALB—Metabolism—AQP1—nephrolithiasis	0.000285	0.00155	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000285	0.00155	CbGpPWpGaD
Prasugrel—ALB—Metabolism—CHRM3—nephrolithiasis	0.000258	0.0014	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.000256	0.00139	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000254	0.00138	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000233	0.00127	CbGpPWpGaD
Prasugrel—CYP2C19—Metabolism—CHRM3—nephrolithiasis	0.000231	0.00126	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000216	0.00118	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000216	0.00118	CbGpPWpGaD
Prasugrel—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000211	0.00115	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000154	0.000838	CbGpPWpGaD
Prasugrel—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.000139	0.000758	CbGpPWpGaD
